Amanote Research
Register
Sign In
PTH-006 Effect of Medication Use on Faecal Occult Blood Test Positivity in the NHS Bowel Cancer Screening Programme
Gut
- United Kingdom
doi 10.1136/gutjnl-2013-304907.494
Full Text
Open PDF
Abstract
Available in
full text
Categories
Gastroenterology
Date
June 1, 2013
Authors
M D Gill
M Bramble
C Rees
Publisher
BMJ
Related search
OC-083 Faecal Occult Blood Test Analysis in the United Kingdom Bowel Cancer Screening Programme
Gut
Gastroenterology
Colonoscopy Quality Assessment in a Mass Population Screening Programme Based on Faecal Occult Blood Test
Revista Espanola de Enfermedades Digestivas
Medicine
Gastroenterology
Colorectal Cancer Prevention. An Approach to Increasing Compliance in a Faecal Occult Blood Test Screening Programme
Journal of Epidemiology and Community Health
Epidemiology
Public Health
Occupational Health
Environmental
Immunochemical Faecal Occult Blood Test: Number of Samples and Positivity Cutoff. What Is the Best Strategy for Colorectal Cancer Screening?
British Journal of Cancer
Cancer Research
Oncology
Clinical Impact of the Immunochemical Fecal Occult Blood Test for Colorectal Cancer Screening in Brazil
Annals of Gastroenterology
Nonsteroidal Anti-Inflammatory Drug-Induced Colopathy: An Uncommon Cause of Positive Immunochemical Faecal Occult Blood Test in Program for Screening of Colorectal Cancer
Vojnosanitetski Pregled
Medicine
Pharmacology
PTH-146 Optimising the Screening Strategy to Reduce Interval Cancers – Initial Experience in the Welsh Bowel Screening Programme
Gut
Gastroenterology
Mass Examination for Colorectal Cancer Screening by Immunological Test of Fecal Occult Blood
Japanese journal of MHTS
Screening for Colorectal Cancer: Reasons for Refusal of Faecal Occult Blood Testing in a General Practice in England.
Journal of Epidemiology and Community Health
Epidemiology
Public Health
Occupational Health
Environmental
